Engineered “mini livers” could be injected as an alternative to transplantation
Sentiment Mix
Geography
Expert Signals
MIT Technology Review - AI
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
A technology developed by Professor Sangeeta Bhatia, SM '93, PhD '97, and colleagues could offer new hope to the thousands of Americans with chronic liver disease who are waiting for an organ transplant or not strong enough to tolerate one.
Supported by 1 story
The liver is involved in regulating blood clotting, removing bacteria from the bloodstream, metabolizing drugs,…
Supported by 1 story
Related Events
Trump may be mystery patient in case of 79yo getting experimental obesity drug
Uncategorized • 6/24/2026
Anthropic suspends new AI models after government directive - AOL.com
Policy & Regulation • 6/24/2026
Micron And Anthropic Announce Strategic Agreement To Scale AI Infrastructure - Pulse 2.0
LLMs • 6/24/2026
Exposing the 'brute force' of AI that is 'trying to make humans redundant'
Uncategorized • 6/24/2026
Meta Faces Growing Pressure From Trump Administration To Submit Advanced AI Models For Federal Testing: Report - Benzinga
Uncategorized • 6/24/2026